Skip to Content

Aarey Drugs & Pharmaceuticals Ltd 524412

Morningstar Rating
INR 53.45 +2.54 (4.99%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

524412 is trading at a 50% discount.
Price
INR 48.01
Fair Value
INR 77.79
Uncertainty
Extreme
1-Star Price
INR 735.88
5-Star Price
INR 61.84
Economic Moat
Kpxcy
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if 524412 is a good fit for your portfolio.

Trading Information

Previous Close Price
INR 50.91
Day Range
INR 49.3153.45
52-Week Range
INR 26.8268.00
Bid/Ask
INR 0.00 / INR 0.00
Market Cap
INR 1.50 Bil
Volume/Avg
38,892 / 9,475

Key Statistics

Price/Earnings (Normalized)
43.79
Price/Sales
0.38
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Aarey Drugs & Pharmaceuticals Ltd is engaged in bulk drug manufacturing and offers products for industrial applications. The company manufactures active pharmaceutical ingredients, intermediates, and specialty chemicals. It is also involved in the trading of industrial solvents and chemicals. The products offered by the company include N-Methyl urea, Dimethyl urea, Mefenamic acid, Metformin, Doxaphylline, BMD among others. The company principally carries its business operations in India.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Value
Total Number of Employees

Valuation

Metric
524412
Price/Earnings (Normalized)
43.79
Price/Book Value
1.09
Price/Sales
0.38
Price/Cash Flow
33.15
Price/Earnings
524412

Financial Strength

Metric
524412
Quick Ratio
1.34
Current Ratio
1.98
Interest Coverage
1.68
Quick Ratio
524412

Profitability

Metric
524412
Return on Assets (Normalized)
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
Return on Assets
524412
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
MKKGY
Merck KGaA ADRJsqyjxhgMylklhx$70.9 Bil
ZTS
Zoetis Inc Class ABnxkwvttWhctg$68.9 Bil
HLN
Haleon PLC ADRWjkswhsrNpwhv$37.5 Bil
TEVA
Teva Pharmaceutical Industries Ltd ADRHlwllqlxMxl$14.7 Bil
VTRS
Viatris IncBvbfwnrKvhbb$13.7 Bil
RDY
Dr Reddy's Laboratories Ltd ADRHkvzfhtmmLhs$11.9 Bil
CTLT
Catalent IncSvcsxxwxzYnbbjb$10.1 Bil
PRGO
Perrigo Co PLCTwkcqbvsTjb$4.1 Bil
CURLF
Curaleaf Holdings IncWfyxnkpSwft$3.6 Bil
PBH
Prestige Consumer Healthcare IncGwwnvyhrHqrrzj$3.5 Bil

Sponsor Center